Abstract:Background/Aims: In this study, we aimed to use bioinformatics tools to identify the specific miRNAs and mRNAs involved in osteogenic differentiation and to further explore the way in which miRNA regulates osteogenic differentiation. Methods: The microarray GSE80614, which includes data from 3 human mesenchymal stromal cells (hMSCs) and 3 hMSCs after 72 hours (hr) of osteogenic differentiation, was used to screen for differentially expressed mRNAs. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses of these mRNAs were conducted using Gene Set Enrichment Analysis (GSEA). Then, the miRanda website was employed to detect the binding sites of DHRS3. In vitro experiments, including RT-PCR and western blotting, were used to detect miR-233 and DHRS3 expression levels 7 and 14 days (d) after the induction of osteogenic differentiation using human bone marrow-derived mesenchymal stem cells (hBMSCs). The target relationship between miR-223 and DHRS3 was confirmed by a dual luciferase assay. ALP (alkaline phosphatase) staining, ARS (Alizarin Red S) staining and western blotting (Runx2, OPN, OCN) were used to detect the level of osteogenic differentiation after transfection with miR-223 mimics and DHRS3 cDNA. Results: In this study, 127 mRNAs differentially expressed during osteogenic differentiation were identified in GSE80614. GO term and KEGG pathway enrichment analyses found that the retinol metabolism pathway was activated during osteogenic differentiation and that DHRS3, which is involved in the pathway, was upregulated. During osteogenic differentiation in hBMSCs, miR-223 was gradually downregulated, while DHRS3 was upregulated. After 14 days of osteogenic differentiation, ALP and ARS staining assay results showed strong ALP activity and extracellular matrix calcification with the inhibition of miR-223 or the overexpression of DHRS3. Furthermore, the expression levels of Runx2, OPN, and OCN were upregulated with the knockdown of miR-223 or the overexpression of DHRS3, while the simultaneous transfection of a miR-223 agomir and DHRS3 cDNA resulted in no significant difference from the negative control (NC) group. Conclusion: The inhibition of miR-223 promotes the osteogenic differentiation of hBMSCs via the upregulation of DHRS3. (C) 2018 The Author(s) Published by S. Karger AG, Basel

Suppression of Osteogenic-Like Differentiation in Human Renal Interstitial Fibroblasts by Mirna-410-3p Through MSX2

Hypoxia-Induced MicroRNA-429 Promotes Differentiation of MC3T3-E1 Osteoblastic Cells by Mediating ZFPM2 Expression

Mirna-34A Inhibits Cell Adhesion by Targeting CD44 in Human Renal Epithelial Cells: Implications for Renal Stone Disease

Long non-coding RNA H19 promotes osteogenic differentiation of renal interstitial fibroblasts through Wnt-β-catenin pathway

Mir-532-3p Inhibits Osteogenic Differentiation in MC3T3-E1 Cells by Downregulating ETS1.

Mir-204 Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells by Targeting Bone Morphogenetic Protein 2

Effect of miR-3960 on osteogenic differentiation

Microrna-338-3p Regulates Osteogenic Differentiation of Mouse Bone Marrow Stromal Stem Cells by Targeting Runx2 and Fgfr2

Mir-203a-5p Decreases The Expression Of Runx2 And Inhibits The Differentiation Of Bmscs To Osteoblasts

MicroRNA-197-3p Inhibits the Osteogenic Differentiation in Osteoporosis by Down-Regulating KLF 10

OLMALINC /OCT4/ BMP2 axis enhances osteogenic-like phenotype of renal interstitial fibroblasts to participate in Randall’s plaque formation

MicroRNA-223 Suppresses Osteoblast Differentiation by Inhibiting DHRS3.

A Runx2/Mir-3960/Mir-2861 Regulatory Feedback Loop During Mouse Osteoblast Differentiation

Mirna-20a Promotes Osteogenic Differentiation Of Human Mesenchymal Stem Cells By Co-Regulating Bmp Signaling

MiR-690, a Runx2-targeted Mirna, Regulates Osteogenic Differentiation of C2C12 Myogenic Progenitor Cells by Targeting NF-kappaB P65

MICRO RNA-451 PROMOTING OSTEOGENESIS OF MESENCHYMAL STEM CELLS BY TARGETING REGULATORY CALCIUM BINDING PROTEIN 39

Mir-214 Suppresses the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells and These Effects Are Mediated Through the Inhibition of the JNK and P38 Pathways.

MicroRNA-409-3p promotes osteoblastic differentiation via activation of Wnt/β-catenin signaling pathway by targeting SCAI

MicroRNA-505 is Involved in the Regulation of Osteogenic Differentiation of MC3T3-E1 Cells Partially by Targeting RUNX2

miR-1827 inhibits osteogenic differentiation by targeting IGF1 in MSMSCs

Mir-664-3p Suppresses Osteoblast Differentiation And Impairs Bone Formation Via Targeting Smad4 And Osterix